EC
ODT

EcoR1 Capital’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

EcoR1 Capital’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,727,261
Closed -$10.8M – 90
2021
Q3 		$10.8M Buy
3,727,261
+2,896,061
+348% +$9.63M 0.38% 32
2021
Q2 		$2.9M Buy
+831,200
New +$2.85M 0.11% 48

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

EcoR1 Capital's ODT Position: Q4 2021 in Review

EcoR1 Capital sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q4 2021, closing a stake of 3,727,261 shares — an estimated $10.8M sold.

EcoR1 Capital first reported a position in ODT in Q2 2021 and held it in 2 quarters. The position peaked at $10.8M in Q3 2021. 50 funds tracked by Wall St. Rank hold ODT as of Q4 2021.

  • EcoR1 Capital reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • EcoR1 Capital sold 3,727,261 Odonate Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $10.8M.
  • EcoR1 Capital first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • EcoR1 Capital's Odonate Therapeutics, Inc. Common Stock position peaked at $10.8M in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q4 2021.

Based on EcoR1 Capital's 13F filing for Q4 2021, filed 14 Feb 2022.